Trial Profile
A Single-Center, Open-label, Single-Arm Study to Evaluate the Effects of Repeat Doses of Subcutaneously Delivered Sumatriptan Via the Intraject System of Local Injection Site Signs in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2012
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Adverse reactions
- 16 Jul 2012 Additional location (USA) added as reported by ClinicalTrials.gov.
- 16 Jul 2012 Additional lead trial investigator (Patricia Chandler) identified as reported by ClinicalTrials.gov.
- 26 Mar 2008 New trial record.